(DHHS) USDoHaHS. The health consequences of smoking - 50 years of progress. A report of the surgeon general. In: Services DoHaH, editor. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
(ACS) ACS. Cancer facts and figures 2016. Atlanta: American Cancer Society; 2016.
Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting smoking among adults - United States, 2000-2015. MMWR Morb Mortal Wkly Rep. 2017;65(52):1457–64.
Malarcher A, Dube S, Shaw L, Babb S, Kaufmann RB. Quitting Smoking Among Adults --- United States, 2001--2010. Morb Mortal Wkly Rep. 2011;60(44):1513–9.
Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 Update. Clinical practice guideline. In: Services UDoHaH, editor. . Rockville: Public Health Service; 2008.
Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007;9(3):315–27.
Heyman GM. Addiction: a disorder of choice. Cambridge: Harvard University Press; 2009.
Levasseur-Moreau J, Fecteau S. Translational application of neuromodulation of decision-making. Brain Stimul. 2012;5(2):77–83.
Kim S, Lee D. Prefrontal cortex and impulsive decision making. Biol Psychiatry. 2011;69(12):1140–6.
Sheffer CE, Mennemeier M, Landes RD, Bickel WK, Brackman S, Dornhoffer J, et al. Neuromodulation of delay discounting, the reflection effect, and cigarette consumption. J Subst Abuse Treat. 2013;45(2):206–14.
Edwards S, Koob GF. Neurobiology of dysregulated motivational systems in drug addiction. Future Neurol. 2010;5(3):393–401.
Botvinick MM, Braver TS, Barch DM, Carter CS, Cohen JD. Conflict monitoring and cognitive control. Psychol Rev. 2001;108(3):624–52.
Baddeley A. Working memory: looking back and looking forward. Nat Rev Neurosci. 2003;4(10):829–39.
Brody AL, Mandelkern MA, London ED, Childress AR, Lee GS, Bota RG, et al. Brain metabolic changes during cigarette craving. Arch Gen Psychiatry. 2002;59(12):1162–72.
McBride D, Barrett SP, Kelly JT, Aw A, Dagher A. Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study. Neuropsychopharmacology. 2006;31(12):2728–38.
Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci. 2005;8(11):1458–63.
Ernst M, Paulus MP. Neurobiology of decision making: a selective review from a neurocognitive and clinical perspective. Biol Psychiatry. 2005;58(8):597–604.
Evans JS. Dual-processing accounts of reasoning, judgment, and social cognition. Annu Rev Psychol. 2008;59:255–78.
Fecteau S, Fregni F, Boggio PS, Camprodon JA, Pascual-Leone A. Neuromodulation of decision-making in the addictive brain. Subst Use Misuse. 2010;45(11):1766–86.
Koob GF, Arends MA, Michel LM. Drugs, addiction, and the brain. Oxford: Elsevier; 2014.
Day AM, Kahler CW, Metrik J, Spillane NS, Tidey JW, Rohsenow DJ. Working memory moderates the association between smoking urge and smoking lapse behavior after alcohol Administration in a Laboratory Analogue Task. Nicotine Tob Res. 2015;17(9):1173–7.
Lerman C, Gu H, Loughead J, Ruparel K, Yang Y, Stein EA. Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function. JAMA Psychiat. 2014;71(5):523–30.
Xu J, Mendrek A, Cohen MS, Monterosso J, Rodriguez P, Simon SL, et al. Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. Biol Psychiatry. 2005;58(2):143–50.
Ernst M, Heishman SJ, Spurgeon L, London ED. Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology. 2001;25(3):313–9.
Koob GF, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol. 2008;59:29–53.
Koob GF, Le Moal M. Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci. 2008;363(1507):3113–23.
McClure SM, Bickel WK. A dual-systems perspective on addiction: contributions from neuroimaging and cognitive training. Ann N Y Acad Sci. 2014;1327:62–78.
Bickel WK, Miller ML, Yi R, Kowal BP, Lindquist DM, Pitcock JA. Behavioral and neuroeconomics of drug addiction: competing neural systems and temporal discounting processes. Drug Alcohol Depend. 2007;90(Suppl 1):S85–91.
Bickel WK, Yi R. Temporal discounting as a measure of executive function: insights from the competing neuro-behavioral decision system hypothesis of addiction. Adv Health Econ Health Serv Res. 2008;20:289–309.
Koffarnus MN, Jarmolowicz DP, Mueller ET, Bickel WK. Changing delay discounting in the light of the competing neurobehavioral decision systems theory: a review. J Exp Anal Behav. 2013;99(1):32–57.
Hanlon CA, Dowdle LT, Austelle CW, DeVries W, Mithoefer O, Badran BW, et al. What goes up, can come down: Novel brain stimulation paradigms may attenuate craving and craving-related neural circuitry in substance dependent individuals. Brain Res. 2015;1628(Pt A):199–209.
McClure SM, Laibson DI, Loewenstein G, Cohen JD. Separate neural systems value immediate and delayed monetary rewards. Science. 2004;306(5695):503–7.
Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357–81.
MacKillop J, Kahler CW. Delayed reward discounting predicts treatment response for heavy drinkers receiving smoking cessation treatment. Drug Alcohol Depend. 2009;104(3):197–203.
Bickel WK, Koffarnus MN, Moody L, Wilson AG. The behavioral- and neuro-economic process of temporal discounting: A candidate behavioral marker of addiction. Neuropharmacology. 2014;76 Pt B:518–27.
Bickel WK, Mellis AM, Snider SE, Moody L, Stein JS, Quisenberry AJ. Novel therapeutics for addiction: behavioral and Neuroeconomic approaches. Curr Treat Options Psychiatry. 2016;3(3):277–92.
McClure SM, Ericson KM, Laibson DI, Loewenstein G, Cohen JD. Time discounting for primary rewards. J Neurosci. 2007;27(21):5796–804.
Vanderveldt A, Oliveira L, Green L. Delay discounting: pigeon, rat, human--does it matter? J Exp Psychol Anim Learn Cogn. 2016;42(2):141–62.
Odum AL. Delay discounting: I'm a k, you're a k. J Exp Anal Behav. 2011;96(3):427–39.
Kirby KN. Bidding on the future: evidence against normative discounting of delayed rewards. J Exp Psychol Gen. 1997;126:54–70.
Mazur JE. An adjusting procedure for studying delayed reinforcement. In: JEM MLC, Nevin JA, Rachlin H, editors. The Effect of Delay and of Intervening Events on Reinforcement Value, Quantitative Analyses of Behavior. 5th ed. Hillsdale: Erlbaum; 1987. p. 55–73.
Ainslie G. Specious reward: A behavioral theory of impulsiveness and impulse control. Psychol Bull. 1975;82:483–96.
Logue AW. Research on self-control: an integrating framework. Behav Brain Sci. 1988;11:665–709.
Bickel WK, Yi R, Kowal BP, Gatchalian KM. Cigarette smokers discount past and future rewards symmetrically and more than controls: is discounting a measure of impulsivity? Drug Alcohol Depend. 2008;96(3):256–62.
Baker F, Johnson MW, Bickel WK. Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude. J Abnorm Psychol. 2003;112(3):382–92.
Bickel WK, Madden GJ. A comparison of measures of relative reinforcing efficacy and behavioral economics: cigarettes and money in smokers. Behav Pharmacol. 1999;10(6–7):627–37.
Mitchell SH. Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology. 1999;146(4):455–64.
Reynolds B. Do high rates of cigarette consumption increase delay discounting? A cross-sectional comparison of adolescent smokers and young-adult smokers and nonsmokers. Behav Processes. 2004;67(3):545–9.
Odum AL, Madden GJ, Bickel WK. Discounting of delayed health gains and losses by current, never- and ex-smokers of cigarettes. Nicotine Tob Res. 2002;4(3):295–303.
Yoon JH, Higgins ST, Heil SH, Sugarbaker RJ, Thomas CS, Badger GJ. Delay discounting predicts postpartum relapse to cigarette smoking among pregnant women. Exp Clin Psychopharmacol. 2007;15(2):176–86.
Krishnan-Sarin S, Reynolds B, Duhig AM, Smith A, Liss T, McFetridge A, et al. Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend. 2007;88(1):79–82.
Sheffer CE, Mackillop J, McGeary J, Landes R, Carter L, Yi R, et al. Delay discounting, locus of control, and cognitive impulsiveness independently predict tobacco dependence treatment outcomes in a highly dependent, lower socioeconomic group of smokers. Am J Addict. 2012;21(3):221–32.
Sheffer CE, Christensen DR, Landes R, Carter LP, Jackson L, Bickel WK. Delay discounting rates: a strong prognostic indicator of smoking relapse. Addict Behav. 2014;39(11):1682–9.
Stanger C, Ryan SR, Fu H, Landes RD, Jones BA, Bickel WK, et al. Delay discounting predicts adolescent substance abuse treatment outcome. Exp Clin Psychopharmacol. 2012;20(3):205–12.
Ballard K, Knutson B. Dissociable neural representations of future reward magnitude and delay during temporal discounting. NeuroImage. 2009;45(1):143–50.
MacKillop J, Amlung MT, Wier LM, David SP, Ray LA, Bickel WK, et al. The neuroeconomics of nicotine dependence: a preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers. Psychiatry Res. 2012;202(1):20–9.
Bickel WK, Jarmolowicz DP, Mueller ET, Koffarnus MN, Gatchalian KM. Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: emerging evidence. Pharmacol Ther. 2012;134(3):287–97.
Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol. 2006;117(12):2584–96.
Hoogendam JM, Ramakers GM, Di Lazzaro V. Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul. 2010;3(2):95–118.
Thickbroom GW. Transcranial magnetic stimulation and synaptic plasticity: experimental framework and human models. Exp Brain Res. 2007;180(4):583–93.
George MS, Nahas Z, Kozel FA, Li X, Denslow S, Yamanaka K, et al. Mechanisms and state of the art of transcranial magnetic stimulation. J ECT. 2002;18(4):170–81.
Di Lazzaro V, Pilato F, Saturno E, Oliviero A, Dileone M, Mazzone P, et al. Theta-burst repetitive transcranial magnetic stimulation suppresses specific excitatory circuits in the human motor cortex. J Physiol. 2005;565(Pt 3):945–50.
Hallett M. Transcranial magnetic stimulation and the human brain. Nature. 2000;406(6792):147–50.
Guse B, Falkai P, Wobrock T. Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm. 2010;117(1):105–22.
Li Y, Wang L, Jia M, Guo J, Wang H, Wang M. The effects of high-frequency rTMS over the left DLPFC on cognitive control in young healthy participants. PLoS One. 2017;12(6):e0179430.
Siebner HR, Rothwell J. Transcranial magnetic stimulation: new insights into representational cortical plasticity. Exp Brain Res. 2003;148(1):1–16.
Pascual-Leone A, Tormos JM, Keenan J, Tarazona F, Canete C, Catala MD. Study and modulation of human cortical excitability with transcranial magnetic stimulation. J Clin Neurophysiol. 1998;15(4):333–43.
Speer AM, Kimbrell TA, Wassermann EM. J DR, Willis MW, Herscovitch P, et al. opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000;48(12):1133–41.
Wu T, Sommer M, Tergau F, Paulus W. Lasting influence of repetitive transcranial magnetic stimulation on intracortical excitability in human subjects. Neurosci Lett. 2000;287(1):37–40.
Perera T, George MS, Grammer G, Janicak PG, Pascual-Leone A, Wirecki TS. The clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimul. 2016;9(3):336–46.
Figner B, Knoch D, Johnson EJ, Krosch AR, Lisanby SH, Fehr E, et al. Lateral prefrontal cortex and self-control in intertemporal choice. Nat Neurosci. 2010;13(5):538–9.
Cho SS, Ko JH, Pellecchia G, Van Eimeren T, Cilia R, Strafella AP. Continuous theta burst stimulation of right dorsolateral prefrontal cortex induces changes in impulsivity level. Brain Stimul. 2010;3(3):170–6.
Knoch D, Fehr E. Resisting the power of temptations: the right prefrontal cortex and self-control. Ann N Y Acad Sci. 2007;1104:123–34.
Knoch D, Gianotti LR, Pascual-Leone A, Treyer V, Regard M, Hohmann M, et al. Disruption of right prefrontal cortex by low-frequency repetitive transcranial magnetic stimulation induces risk-taking behavior. J Neurosci. 2006;26(24):6469–72.
Fecteau S, Knoch D, Fregni F, Sultani N, Boggio P, Pascual-Leone A. Diminishing risk-taking behavior by modulating activity in the prefrontal cortex: a direct current stimulation study. J Neurosci. 2007;27(46):12500–5.
Fecteau S, Pascual-Leone A, Zald DH, Liguori P, Theoret H, Boggio PS, et al. Activation of prefrontal cortex by transcranial direct current stimulation reduces appetite for risk during ambiguous decision making. J Neurosci. 2007;27(23):6212–8.
Rachid F. Neurostimulation techniques in the treatment of nicotine dependence: a review. Am J Addict. 2016;25(6):436–51.
Wing VC, Barr MS, Wass CE, Lipsman N, Lozano AM, Daskalakis ZJ, et al. Brain stimulation methods to treat tobacco addiction. Brain Stimul. 2012;6(3):221–30.
Barr MS, Farzan F, Wing VC, George TP, Fitzgerald PB, Daskalakis ZJ. Repetitive transcranial magnetic stimulation and drug addiction. Int Rev Psychiatry. 2011;23(5):454–66.
Preston G, Anderson E, Silva C, Goldberg T, Wassermann EM. Effects of 10 Hz rTMS on the neural efficiency of working memory. J Cogn Neurosci. 2010;22(3):447–56.
Esslinger C, Schuler N, Sauer C, Gass D, Mier D, Braun U, et al. Induction and quantification of prefrontal cortical network plasticity using 5 Hz rTMS and fMRI. Hum Brain Mapp. 2014;35(1):140–51.
Chen AC, Oathes DJ, Chang C, Bradley T, Zhou ZW, Williams LM, et al. Causal interactions between fronto-parietal central executive and default-mode networks in humans. Proc Natl Acad Sci U S A. 2013;110(49):19944–9.
Baeken C, De Raedt R. Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neurocircuitry in unipolar depression. Dialogues Clin Neurosci. 2011;13(1):139–45.
Kravitz AV, Tomasi D, LeBlanc KH, Baler R, Volkow ND, Bonci A, et al. Cortico-striatal circuits: Novel therapeutic targets for substance use disorders. Brain Res. 2015;1628(Pt A):186–98.
Cooke SF, Bliss TV. Plasticity in the human central nervous system. Brain. 2006;129(Pt 7):1659–73.
Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361(6407):31–9.
Serafini G, Pompili M, Belvederi Murri M, Respino M, Ghio L, Girardi P, et al. The effects of repetitive transcranial magnetic stimulation on cognitive performance in treatment-resistant depression. A systematic review. Neuropsychobiology. 2015;71(3):125–39.
Perkins KA, Conklin CA, Levine MD. Cognitive-behavioral therapy for smoking cessation: a practical guidebook to the most effective treatments. New York: Routledge; 2008.
Abrams DB, Niaura R, Brown RA, Emmons KM, Goldstein MG, Monti PM. In: Barlow DH, editor. The tobacco dependence treatment handbook: a guide to best practices. New York: Guilford Press; 2003.
Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy for depression. New York: Guilford; 1979.
Vedeniapin A, Cheng L, George MS. Feasibility of simultaneous cognitive behavioral therapy and left prefrontal rTMS for treatment resistant depression. Brain Stimul. 2010;3(4):207–10.
Osuch EA, Benson BE, Luckenbaugh DA, Geraci M, Post RM, McCann U. Repetitive TMS combined with exposure therapy for PTSD: a preliminary study. J Anxiety Disord. 2009;23(1):54–9.
Miniussi C, Vallar G. Brain stimulation and behavioural cognitive rehabilitation: a new tool for neurorehabilitation? Neuropsychol Rehabil. 2011;21(5):553–9.
Sheffer CE, Bickel WK, Brandon TH, Franck CT, Deen D, Panissidi L, et al. Preventing relapse to smoking with transcranial magnetic stimulation: feasibility and potential efficacy. Drug Alcohol Depend. 2018;182:8–18.
Shiffman S, Shumaker SA, Abrams DB, Cohen S, Garvey A, Grunberg NE, et al. Models of smoking relapse. Health Psychol. 1986;5(Suppl):13–27.
Brandon TH, Collins BN, Juliano LM, Lazev AB. Preventing relapse among former smokers: a comparison of minimal interventions through telephone and mail. J Consult Clin Psychol. 2000;68(1):103–13.
Marlatt G. Situational determinants of relapse and skill-training interventions. In: Marlatt G, Gordon J, editors. Relapse prevention. New York: Guilford Press; 1985.
Ting N. In: KK MG, Samet J, Tsiatis A, Wong W, editors. Dose finding in drug development. New York: Springer Science+business Media, Inc.; 2006.
Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the international workshop on the safety of repetitive transcranial magnetic stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol. 1998;108(1):1–16.
Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety of TMSCG. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008–39.
Teng S, Guo Z, Peng H, Xing G, Chen H, He B, et al. High-frequency repetitive transcranial magnetic stimulation over the left DLPFC for major depression: session-dependent efficacy: a meta-analysis. Eur Psychiatry. 2017;41:75–84.
Anderson B, Mishory A, Nahas Z, Borckardt JJ, Yamanaka K, Rastogi K, et al. Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. J ECT. 2006;22(1):49–53.
Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med. 2000;19(22):3127–31.
Bureau USC. QuickFacts: Erie County, New York; 2019.
Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Screening questionnaire before TMS: an update. Clin Neurophysiol. 2011;122(8):1686.
Radomsky AS, Rachman S, Thordarson DS, McIsaac HK, Teachman BA. The claustrophobia questionnaire. J Anxiety Disord. 2001;15(4):287–97.
Koffarnus MN, Bickel WK. A 5-trial adjusting delay discounting task: accurate discount rates in less than one minute. Exp Clin Psychopharmacol. 2014;22(3):222–8.
Reitzel LR, Businelle MS, Kendzor DE, Li Y, Cao Y, Castro Y, et al. Subjective social status predicts long-term smoking abstinence. BMC Public Health. 2011;11:135.
Reise SP, Moore TM, Sabb FW, Brown AK, London ED. The Barratt impulsiveness Scale-11: reassessment of its structure in a community sample. Psychol Assess. 2013;25(2):631–42.
Sansone G, Fong GT, Hall PA, Guignard R, Beck F, Mons U, et al. Time perspective as a predictor of smoking status: findings from the international tobacco control (ITC) surveys in Scotland, France, Germany, China, and Malaysia. BMC Public Health. 2013;13(1):346.
Cohen S, Lichtenstein E. Perceived stress, quitting smoking, and smoking relapse. Health Psychol. 1990;9(4):466–78.
Watson D, Clark L, Tellegen A. Development and validation of brief measures of positive and negative affect. The PANAS scale. J Pers Soc Psychol. 1988;54:1063–70.
Radloff LS. The CES-D scale : a self-report depression scale for research in the general population. Appl Psychol Measur. 1977;1(3):385–401.
Spielberger CD. State-trait anxiety inventory (form Y). In: Hersen M, Bellack AS, editors. Dictionary of behavioral assessment techniques. New York: Pergamon; 1988. p. 448–50.
Jacob KL, Christopher MS, Neuhaus EC. Development and validation of the cognitive-behavioral therapy skills questionnaire. Behav Modif. 2011;35(6):595–618.
Lingler JH, Schmidt KL, Gentry AL, Hu L, Terhorst LA. A new measure of research participant burden: brief report. J Empir Res Hum Res Ethics. 2014;9(4):46–9.
James KE, Bloch DA, Lee KK, Kraemer HC, Fuller RK. An index for assessing blindness in a multi-Centre clinical trial: disulfiram for alcohol cessation--a VA cooperative study. Stat Med. 1996;15(13):1421–34.
Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-consumpton. In: Allen J, Litten RZ, editors. Measuring alcohol consumption:psychosocial and biological methods. Totowa: Humana Press; 1992. p. 41–72.
Cieslik EC, Zilles K, Caspers S, Roski C, Kellermann TS, Jakobs O, et al. Is there "one" DLPFC in cognitive action control? Evidence for heterogeneity from co-activation-based parcellation. Cereb Cortex. 2013;23(11):2677–89.
Fitzgerald PB, Maller JJ, Hoy KE, Thomson R, Daskalakis ZJ. Exploring the optimal site for the localization of dorsolateral prefrontal cortex in brain stimulation experiments. Brain Stimul. 2009;2(4):234–7.
George MS, Taylor JJ, Short EB. The expanding evidence base for rTMS treatment of depression. Curr Opin Psychiatry. 2013;26(1):13–8.
verification SSoB. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149–59.
Fagerstrom K, Russ C, Yu CR, Yunis C, Foulds J. The Fagerstrom test for nicotine dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data. Nicotine Tob Res. 2012;14(12):1467–73.
Toll BA, Cooney NL, McKee SA, O'Malley SS. Do daily interactive voice response reports of smoking behavior correspond with retrospective reports? Psychol Addict Behav. 2005;19(3):291–5.
Collins LM, Dziak JJ, Kugler KC, Trail JB. Factorial experiments: efficient tools for evaluation of intervention components. Am J Prev Med. 2014;47(4):498–504.
Collins LM, Trail JB, Kugler KC, Baker TB, Piper ME, Mermelstein RJ. Evaluating individual intervention components: making decisions based on the results of a factorial screening experiment. Transl Behav Med. 2014;4(3):238–51.
Collins LM, Dziak JJ, Li R. Design of experiments with multiple independent variables: a resource management perspective on complete and reduced factorial designs. Psychol Methods. 2009;14(3):202–24.
Collins LM, Chakraborty B, Murphy SA, Strecher V. Comparison of a phased experimental approach and a single randomized clinical trial for developing multicomponent behavioral interventions. Clin Trials. 2009;6(1):5–15.
Hosmer DW, Lemeshow S. Applied survival analysis. New York: Wiley; 1999.
Cox DR. Regresson models and life-tables. J R Stat Soc Ser B Methodol. 1972;34(2):187–220.
Shiffman S, Scharf DM, Shadel WG, Gwaltney CJ, Dang Q, Paton SM, et al. Analyzing milestones in smoking cessation: illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol. 2006;74(2):276–85.
Efron B, Tibshirani RJ. An introduction to the bootstrap. London. New York: Chapman & Hall Ltd; 1993.
Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, et al. How we design feasibility studies. Am J Prev Med. 2009;36(5):452–7.
Rounsaville BJ, Carroll KM, Onken LS. A stage model of behavioral therapies research: getting started and moving on from stage I Clinical Psychology. Sci Pract. 2001;8(2):133–42.
Nguyen KH, Gordon LG. Cost-effectiveness of repetitive transcranial magnetic stimulation versus antidepressant therapy for treatment-resistant depression. Value Health. 2015;18(5):597–604.
Simpson KN, Welch MJ, Kozel FA, Demitrack MA, Nahas Z. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis. Adv Ther. 2009;26(3):346–68.
Hughes JR, Callas PW. Definition of a quit attempt: a replication test. Nicotine Tob Res. 2010;12(11):1176–9.